MONDAY, Oct. 7, 2024 — For patients with hidradenitis suppurativa (HS), bimekizumab is safe and efficacious over two years, according to a study presented at the annual meeting of the European Academy of Dermatology and Venereology, held from Sept…Original Article
Bimekizumab Safe, Efficacious Over Two Years for Hidradenitis Suppurativa
MONDAY, Oct. 7, 2024 — For patients with hidradenitis suppurativa (HS), bimekizumab is safe and efficacious over two years, according to a study presented at the annual meeting of the European Academy of Dermatology and Venereology, held from Sept…
